The structural heart disease interventional imager rationale, skills and training: a position paper of the European Association of Cardiovascular Imaging.

Percutaneous treatment of structural heart disease Structural heart disease  Interventional imaging

Journal

European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788

Informations de publication

Date de publication:
28 04 2021
Historique:
received: 05 01 2021
pubmed: 11 2 2021
medline: 6 8 2021
entrez: 10 2 2021
Statut: ppublish

Résumé

Percutaneous therapeutic options for an increasing variety of structural heart diseases (SHD) have grown dramatically. Within this context of continuous expansion of devices and procedures, there has been increased demand for physicians with specific knowledge, skills, and advanced training in multimodality cardiac imaging. As a consequence, a new subspecialty of 'Interventional Imaging' for SHD interventions and a new dedicated professional figure, the 'Interventional Imager' with specific competencies has emerged. The interventional imager is an integral part of the heart team and plays a central role in decision-making throughout the patient pathway, including the appropriateness and feasibility of a procedure, pre-procedural planning, intra-procedural guidance, and post-procedural follow-up. However, inherent challenges exist to develop a training programme for SHD imaging that differs from traditional cardiovascular imaging pathways. The purpose of this document is to provide the standard requirements for the training in SHD imaging, as well as a starting point for an official certification process for SHD interventional imager.

Identifiants

pubmed: 33564848
pii: 6132065
doi: 10.1093/ehjci/jeab005
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

471-479

Investigateurs

Philippe Bertrand (P)
Victoria Delgado (V)
Bernard Gerber (B)
Ivan Stankovic (I)

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Auteurs

Eustachio Agricola (E)

Cardiovascular Imaging Unit, San Raffaele Hospital, IRCCS, Vita-Salute San Raffaele University, Milan, Italy.

Francesco Ancona (F)

Cardiovascular Imaging Unit, San Raffaele Hospital, Milan, Italy.

Eric Brochet (E)

Cardiology Department, Hôpital BICHAT Paris, France.

Erwan Donal (E)

Cardiologie, CHU de RENNES, LTSI UMR1099, INSERM, Université de Rennes-1, Rennes, France.

Marc Dweck (M)

Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.

Francesco Faletra (F)

Director of cardiac imaging service, . Cardiocentro Ticino Switzerland.

Patrizio Lancellotti (P)

Department of Cardiology, CHU SartTilman, University of Liège Hospital, GIGA Cardiovascular Sciences, Liège, Belgium.
Gruppo Villa Maria Care and Research, Maria Cecilia Hospital, Cotignola, and Anthea Hospital, Bari, Italy.

Hani Mahmoud-Elsayed (H)

Consultant Cardiologist, Director of Echocardiography Lab, Al-Nas Hospital, Cairo, Egypt.

Nina Ajmone Marsan (NA)

Department of Cardiology, Leiden University Medical Center, The Netherlands.

Pal Maurovich-Hovart (P)

Medical Imaging Centre, Semmelweis University, Budapest, Hungary.

Mark Monaghan (M)

Director of Non-Invasive Cardiology, King's College Hospital, London, UK.

José Ribeiro (J)

Thorax and Circulation Unit Director, Gaia Hospital Center, Oporto, Portugal.

Leyla Elif Sade (LE)

University of Baskent, Department of Cardiology, Ankara, Turkey.

Martin Swaans (M)

Department of Cardiology, St.Antonius Hospital, Nieuwegein, The Netherlands.

Ralph Stephan Von Bardeleben (RS)

Dep. of Cardiology I, Heart Valve Center, Universitätsmedizin Mainz, Mainz, Germany.

Nina Wunderlich (N)

Cardiovascular Center Darmstadt, Darmstadt, Germany.

Jose-Luis Zamorano (JL)

University Hospital Ramon y Cajal, Madrid, Spain.

Bogdan A Popescu (BA)

Department of Cardiology, University of Medicine and Pharmacy 'Carol Davila' - Euroecolab, Emergency Institute for Cardiovascular Diseases 'Prof. Dr. C. C. Iliescu', Bucharest, Romania.

Bernard Cosyns (B)

Cardiology Department, Centrum voor Hart en Vaatziekten (CHVZ), Universitair ziekenhuis Brussel, Brussels, Belgium.

Thor Edvardsen (T)

Dept of Cardiology, Oslo University Hospital, Pb 4950 Nydalen, 0424, Oslo, Norway.
Faculty of Medicine, University of Oslo, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH